| BMSRX | VIMSX | BMSRX / VIMSX | |
| Total Expense Ratio | 1.59 | 0.17 | 935% |
| Annual Report Gross Expense Ratio | 1.67 | 0.17 | 982% |
| Fund Existence | 9 years | 28 years | - |
| Gain YTD | 4.289 | 7.167 | 60% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.17B | 199B | 1% |
| Annual Yield % from dividends | 0.10 | 1.38 | 7% |
| Returns for 1 year | -8.09 | 3.39 | -239% |
| Returns for 3 years | 23.15 | 35.44 | 65% |
| Returns for 5 years | 17.65 | 45.66 | 39% |
| Returns for 10 years | N/A | 133.73 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FGSKX | 57.02 | 0.06 | +0.11% |
| Federated Hermes MDT Mid Cap Growth R6 | |||
| RYAZX | 208.10 | N/A | N/A |
| Rydex S&P SmallCap 600 Pure Value H | |||
| FMFMX | 18.02 | N/A | N/A |
| Fidelity Advisor Series Equity Gr | |||
| IVGSX | 19.62 | -0.03 | -0.15% |
| VY® Invesco Growth and Income S | |||
| BRWSX | 28.05 | -0.32 | -1.13% |
| MFS Blended Research Growth Eq R2 | |||